BDR Pharmaceuticals Sues FDA Over Phathom Pharmaceuticals' VOQUEZNA Exclusivity

AI-summarized · Neutrality-checked

BDR Pharmaceuticals International Pvt. Ltd. filed a lawsuit against the U.S. Food and Drug Administration. The legal action challenged the agency's decision to grant marketing exclusivity to Phathom Pharmaceuticals for the product VOQUEZNA.

Sources and context

Know where. Know why.